CAS: 1001600-54-9

MV1

MV1 is an IAP antagonist. When combined with HaloTag ligand, MV1 causes protein knockdown of HaloTag-fused proteins.

MV1 is a protein that belongs to the group of calcium binding proteins. It has been shown to be an important biomarker for active antiretroviral therapy in HIV-infected patients. MV1 is also expressed at high levels in primary cells, such as T lymphocytes and macrophages, and can be used as a marker for cell lysis in model organisms, such as mice. The protein has been shown to have potential therapeutic applications in the treatment of obesity-related disorders by regulating body mass index (BMI). MV1 has also been shown to bind bacterial strains and viruses, which makes it a potential diagnostic tool. This protein can also act as a vector for experimental models.